Safety and Tolerability Study of the VAC ∆6 Vaccine in Volunteers Aged 18-40 Years

Conditions:   Smallpox;   Monkeypox;   Cowpox;   Vaccinia Virus Infection Interventions:   Biological: VAC∆6 vaccine - оnce at a dose of 10⁶ PFU;   Biological: VAC∆6 vaccine - once at a dose of 10⁷ PFU;   Biological: VAC∆6 vaccine - twice at a dose of 10⁶ PFU;   Biological: Live smallpox vaccine (Smallpox vaccine) + The OspaVir® inactivated smallpox vaccine Sponsor:   Federal Budgetary Research Institution State Research Center of Virology and Biotechnology " Vector " Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials